ABOUT

Leadership

PearlsInMires,Pioneering the global market with innovative technology

  • ‘Creative’Thinking outside the box

  • ‘Reliable’Confidence in technology

  • ‘Pioneering’Discovering Innovation

PearlsInMires
Experienced team in basic and clinical drug development.
Over 10 years of collaboration, dedicated to improving patients' lives with happiness.

Leveraging extensive experience in R&D

We conduct systematic research to secure optimal efficacy data, drawing on our years of R&D experience. We collaborate with major national research institutes and CROs to develop key items successfully. Our R&D department is dedicated to discovering new drug candidates through reliable research, focusing on securing optimal efficacy and mechanisms for clinical application.

Clinical Development

Our highly skilled clinical development experts, with extensive experience in various clinical trials, collaborate with leading university hospitals to establish efficient clinical development strategies tailored to our key products. From domestic to global clinical trials, we are committed to securing high-quality clinical data through the successful execution of all clinical development phases.

BD & Strategy Planning and Finance

PearlsInMires has a dedicated business development department, partnering with a global BD company based in the United States to transfer technology for its main items. To achieve development milestones and successfully transfer technology, we regularly monitor the anticancer drug market, assess demand, and connect with global pharmaceutical companies through various channels. We also focus on successful joint development through domestic and international open innovation programs.

"PearlsInMires has an active and flexible structure, with experts working seamlessly together like cogs in a wheel."

Investors
  • EVERGREEN Investment Partners
    (South Korea)
  • Smilegate Investment
    (South Korea)
  • Handok/INNOCUBE
    (South Korea)